Ethyl pyruvate preserves cardiac function and attenuates oxidative injury after prolonged myocardial ischemia

被引:93
作者
Woo, YJ
Taylor, MD
Cohen, JE
Jayasankar, V
Bish, LT
Burdick, J
Pirolli, TJ
Berry, MF
Hsu, V
Grand, T
机构
[1] Univ Penn, Sch Med, Dept Surg,Div Cardiothorac Surg, Minimally Invas & Robot Cardiac Surg Program, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA
关键词
D O I
10.1016/j.jtcvs.2003.11.032
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Myocardial injury and dysfunction following ischemia are mediated in part by reactive oxygen species. Pyruvate, a key glycolytic intermediary, is an effective free radical scavenger but unfortunately is limited by aqueous instability. The ester derivative, ethyl pyruvate, is stable in solution and should function as an antioxidant and energy precursor. This study sought to evaluate ethyl pyruvate as a myocardial protective agent in a rat model of ischemia-reperfusion injury. Methods: Rats underwent 30-minute ischemia and 30-minute reperfusion of the left anterior descending coronary artery territory. Immediately prior to both ischemia and reperfusion, animals received an intravenous bolus of either ethyl pyruvate (n = 26) or vehicle control (n = 26). Myocardial high-energy phosphate levels were determined by adenosine triphosphate assay, oxidative injury was measured by lipid peroxidation assay, infarct size was quantified by triphenyltetrazolium chloride staining, and cardiac function was assessed in vivo. Results: Ethyl pyruvate administration significantly increased myocardial adenosine triphosphate levels compared with control (87.6 +/- 29.2 nmol/g vs 10.0 +/- 2.4 nmol/g, P = .03). In ischemic myocardium, ethyl pyruvate reduced oxidative injury compared with control (63.8 +/- 3.3 nmol/g vs 89.5 +/- 3.0 nmol/g, P <.001). Ethyl pyruvate diminished infarct size as a percentage of area at risk (25.3% +/- 1.5% vs 33.6% +/- 2.1 %, P = .005). Ethyl pyruvate improved myocardial function compared with control (maximum pressure: 86.6 +/- 2.9 mm Hg vs 73.5 +/- 2.5 mm Hg, P < .001; maximum rate of pressure rise: 3518 +/- 243 mm Hg/s vs 2703 +/- 175 mm Hg/s, P =.005; maximal rate of ventricular systolic volume ejection: 3097 +/- 479 muL/s vs 2120 +/- 287 muL/s, P = .04; ejection fraction: 41.9% +/- 3.8% vs 31.4% +/- 4.1%, P = .03; cardiac output: 26.7 +/- 0.9 mL/min vs 22.7 +/- 1.3 mL/min, P = .01; and end-systolic pressure-volume relationship slope: 1.09 +/- 0.22 vs 0.59 +/- 0.2, P = .02). Conclusions: In this study of myocardial ischemia-reperfusion injury, ethyl pyruvate enhanced myocardial adenosine triphosphate levels, attenuated myocardial oxidative injury, decreased infarct size, and preserved cardiac function.
引用
收藏
页码:1262 / 1269
页数:8
相关论文
共 29 条
  • [1] Antioxidant pyruvate inhibits cardiac formation of reactive oxygen species through changes in redox state
    Bassenge, E
    Sommer, O
    Schwemmer, M
    Bünger, R
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2000, 279 (05): : H2431 - H2438
  • [2] Glutathione protects against myocardial ischemia-reperfusion injury by detoxifying peroxynitrite
    Cheung, PY
    Wang, WJ
    Schulz, R
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2000, 32 (09) : 1669 - 1678
  • [3] NONENZYMATIC DECARBOXYLATION OF PYRUVATE
    CONSTANTOPOULOS, G
    BARRANGER, JA
    [J]. ANALYTICAL BIOCHEMISTRY, 1984, 139 (02) : 353 - 358
  • [4] PYRUVATE ENHANCES RECOVERY OF RAT HEARTS AFTER ISCHEMIA AND REPERFUSION BY PREVENTING FREE-RADICAL GENERATION
    DEBOER, LWV
    BEKX, PA
    HAN, LH
    STEINKE, L
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (05): : H1571 - H1576
  • [5] Attenuation of sugar cataract by ethyl pyruvate
    Devamanoharan, PS
    Henein, M
    Ali, AH
    Varma, SD
    [J]. MOLECULAR AND CELLULAR BIOCHEMISTRY, 1999, 200 (1-2) : 103 - 109
  • [6] Antioxidative properties of pyruvate and protection of the ischemic rat heart during cardioplegia
    Dobsak, P
    Courderot-Masuyer, C
    Zeller, M
    Vergely, C
    Laubriet, A
    Assem, M
    Eicher, JC
    Teyssier, JR
    Wolf, JE
    Rochette, L
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1999, 34 (05) : 651 - 659
  • [7] Potentiation of beta-adrenergic inotropic response by pyruvate in failing human myocardium
    Hermann, HP
    Zeitz, O
    Lehnart, SE
    Keweloh, B
    Datz, N
    Hasenfuss, G
    Janssen, PML
    [J]. CARDIOVASCULAR RESEARCH, 2002, 53 (01) : 116 - 123
  • [8] JOHNSON DL, 1987, SURGERY, V102, P334
  • [9] Pyruvate: Metabolic protector of cardiac performance
    Mallet, RT
    [J]. PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 2000, 223 (02): : 136 - 148
  • [10] Pyruvate restores contractile function and antioxidant defenses of hydrogen peroxide-challenged myocardium
    Mallet, RT
    Squires, JE
    Bhatia, S
    Sun, J
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2002, 34 (09) : 1173 - 1184